Literature DB >> 1340777

Release of vasoactive substances during cardiopulmonary bypass.

S W Downing1, L H Edmunds.   

Abstract

Cardiopulmonary bypass is associated with bleeding and thrombotic complications, massive fluid shifts, and cellular and hormonal defense reactions that are collectively termed "the whole body inflammatory response." A host of vasoactive substances are produced, released or altered during cardiopulmonary bypass. These hormones, autacoids, and cytokines react with specific receptor proteins distributed throughout the body, and mediate the vascular smooth muscle and endothelial cell contractions that are responsible for much of the morbidity associated with open heart operations. This essay briefly reviews the actions, sources, and perturbations of the approximately 25 vasoactive substances known or believed to be altered by cardiopulmonary bypass, and provides an introductory reference list.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1340777     DOI: 10.1016/0003-4975(92)90113-i

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

Review 1.  Brain protection during cardiac surgery: circa 2012.

Authors:  John W Hammon
Journal:  J Extra Corpor Technol       Date:  2013-06

2.  Perioperative cytokine release during coronary artery bypass grafting in patients of different ages.

Authors:  A Roth-Isigkeit; J Schwarzenberger; T v Borstel; H Gehring; E Ocklitz; K Wagner; P Schmucker; M Seyfarth
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

3.  Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review.

Authors:  John T Denny; Andrew T Burr; Fred Balzer; James T Tse; Julia E Denny; Darrick Chyu
Journal:  Exp Ther Med       Date:  2015-03-12       Impact factor: 2.447

4.  Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.

Authors:  M H Liu; S H Floten; Q Yang; G W He
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

5.  The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

6.  Pulmonary hypertension in cardiac surgery.

Authors:  André Denault; Alain Deschamps; Jean-Claude Tardif; Jean Lambert; Louis Perrault
Journal:  Curr Cardiol Rev       Date:  2010-02

7.  Successful treatment of a patient with severe pulmonary hypertension due to perivalvular leakage at aortic and mitral positions after aortic and mitral valve replacement.

Authors:  Takashi Miura; Hiroshi Nishida; Akihiko Kawai; Tomohiro Maeda; Hiromi Kurosawa; Hitoshi Koyanagi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-10-15

8.  Preoperative evaluation of patients with liver cirrhosis undergoing open heart surgery.

Authors:  Takashi Murashita; Tatsuhiko Komiya; Nobushige Tamura; Genichi Sakaguchi; Taira Kobayashi; Tomokuni Furukawa; Akihito Matsushita; Gengo Sunagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-06-17

Review 9.  Limiting excessive postoperative blood transfusion after cardiac procedures. A review.

Authors:  V A Ferraris; S P Ferraris
Journal:  Tex Heart Inst J       Date:  1995

10.  Elevated S100A12 and sRAGE are associated with increased length of hospitalization after non-urgent coronary artery bypass grafting surgery.

Authors:  Ricardo Scheiber-Camoretti; Amit Mehrotra; Ling Yan; Jai Raman; John F Beshai; Marion A Hofmann Bowman
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.